Home > Insider Trading > Filing (0001209191-11-012111)

Filing Details

Accession Number:: 0001209191-11-012111
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-23 17:15:44
Reporting Period:: 2011-02-18

Filing Date:: 2011-02-23
Accepted Time:: 2011-02-23 17:15:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1113481	Medicines Co	MDCO	Pharmaceutical Preparations (2834)	043324394

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1277478	Glenn Sblendorio	8 Sylvan Way Parsippany NJ 07054	Executive Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-02-18	18,000	$17.45	97,451	No	4	A	Direct
Common Stock	Acquisiton	2011-02-18	6,875	$7.31	104,326	No	4	M	Direct
Common Stock	Disposition	2011-02-18	6,875	$16.96	97,451	No	4	S	Direct
Common Stock	Disposition	2011-02-18	12,551	$16.87	84,900	No	4	S	Direct
Common Stock	Disposition	2011-02-18	3,435	$16.92	81,465	No	4	S	Direct
Common Stock	Disposition	2011-02-22	2,818	$17.28	78,647	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Acquisiton	2011-02-18	90,000	$17.45	90,000	$17.45
Common Stock	Option (right to buy)	Disposition	2011-02-18	6,875	$7.31	6,875	$7.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
90,000		2021-02-18	No	4	A	Direct
625	2011-02-18	2014-02-19	No	4	M	Direct

Footnotes

The range of prices for the transactions reported on this line is between $16.94 and $16.99 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
The range of prices for the transactions reported on this line is between $16.83 and $16.93 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
The range of prices for the transactions reported on this line is between $16.91 and $16.94 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
The range of prices for the transactions reported on this line is between $17.10 and $17.61 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
The option vests in 48 equal monthly installments beginning on 3/18/2011.
As of 02/18/2011, the original grant (30,000 shares granted on 02/19/2010) was vested with respect to 7,500 of the shares covered thereby and the remaining 22,500 shares covered by this option vest in equal monthly installments ending on 02/19/2014. After the exercise of the options reported hereby, as of 02/18/2011, 625 of the shares covered by the option were vested but not exercised.